Avidity Partners Management as of June 30, 2025
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 55 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 7.8 | $39M | 1.5M | 26.00 | |
| Boston Scientific Corporation (BSX) | 6.9 | $35M | 322k | 107.41 | |
| Natera (NTRA) | 6.7 | $34M | 199k | 168.94 | |
| Dianthus Therapeutics (DNTH) | 6.5 | $33M | 1.7M | 18.63 | |
| EXACT Sciences Corporation (EXAS) | 3.8 | $19M | 355k | 53.14 | |
| Tenet Healthcare Corp Com New (THC) | 3.7 | $19M | 106k | 176.00 | |
| Dex (DXCM) | 3.7 | $18M | 211k | 87.29 | |
| Danaher Corporation (DHR) | 3.5 | $18M | 90k | 197.54 | |
| Hinge Health Cl A (HNGE) | 3.3 | $17M | 322k | 51.75 | |
| Intuitive Surgival Com New (ISRG) | 2.9 | $15M | 27k | 543.41 | |
| Genmab A/s Sponsored Ads (GMAB) | 2.7 | $13M | 650k | 20.66 | |
| Repligen Corporation (RGEN) | 2.6 | $13M | 107k | 124.38 | |
| Thermo Fisher Scientific (TMO) | 2.4 | $12M | 30k | 405.46 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 2.3 | $12M | 690k | 16.76 | |
| Jade Biosciences Com New (JBIO) | 2.2 | $11M | 1.1M | 9.99 | |
| Phathom Pharmaceuticals (PHAT) | 2.0 | $10M | 1.1M | 9.59 | |
| UnitedHealth (UNH) | 2.0 | $10M | 32k | 311.97 | |
| Mckesson Corp Com New (MCK) | 2.0 | $9.9M | 14k | 732.78 | |
| Axsome Therapeutics (AXSM) | 2.0 | $9.9M | 95k | 104.39 | |
| AmerisourceBergen (COR) | 2.0 | $9.8M | 33k | 299.85 | |
| Healthequity (HQY) | 1.9 | $9.6M | 92k | 104.76 | |
| Encompass Health Corp (EHC) | 1.8 | $9.1M | 74k | 122.63 | |
| Revolution Medicines (RVMD) | 1.7 | $8.4M | 229k | 36.79 | |
| Akero Therapeutics (AKRO) | 1.4 | $7.2M | 134k | 53.36 | |
| Omada Health (OMDA) | 1.4 | $7.1M | 391k | 18.30 | |
| Beam Therapeutics (BEAM) | 1.4 | $7.0M | 409k | 17.01 | |
| Humana (HUM) | 1.3 | $6.7M | 28k | 244.48 | |
| Perspective Therapeutics Com New (CATX) | 1.3 | $6.4M | 1.9M | 3.44 | |
| Organon & Co (OGN) | 1.2 | $6.2M | 640k | 9.68 | |
| Bridgebio Pharma (BBIO) | 1.2 | $6.0M | 140k | 43.18 | |
| Insmed Com Par $.01 (INSM) | 1.2 | $5.9M | 59k | 100.64 | |
| Madrigal Pharmaceuticals Com New (MDGL) | 1.1 | $5.8M | 19k | 302.64 | |
| Ultragenyx Pharmaceutical (RARE) | 1.1 | $5.6M | 154k | 36.36 | |
| Context Therapeutics (CNTX) | 1.0 | $4.9M | 7.5M | 0.66 | |
| Syndax Pharmaceuticals (SNDX) | 0.9 | $4.6M | 490k | 9.37 | |
| Oruka Therapeutics (ORKA) | 0.8 | $3.9M | 352k | 11.21 | |
| Immunic (IMUX) | 0.8 | $3.9M | 5.6M | 0.70 | |
| Arcutis Biotherapeutics (ARQT) | 0.7 | $3.8M | 268k | 14.02 | |
| Doximity Cl A (DOCS) | 0.7 | $3.7M | 60k | 61.34 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $3.4M | 108k | 31.30 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.6 | $3.2M | 34k | 94.58 | |
| Uniqure Nv SHS (QURE) | 0.6 | $2.9M | 207k | 13.94 | |
| Apogee Therapeutics (APGE) | 0.6 | $2.8M | 65k | 43.43 | |
| Soleno Therapeutics (SLNO) | 0.5 | $2.7M | 32k | 83.78 | |
| Cardinal Health (CAH) | 0.5 | $2.5M | 15k | 168.00 | |
| Silverback Therapeutics (SPRY) | 0.5 | $2.4M | 140k | 17.45 | |
| Kezar Life Sciences Com New (KZR) | 0.5 | $2.3M | 503k | 4.58 | |
| Intellia Therapeutics (NTLA) | 0.4 | $2.2M | 232k | 9.38 | |
| Moonlake Immunotherapeutics A Ord (MLTX) | 0.4 | $1.8M | 39k | 47.20 | |
| Arvinas Ord (ARVN) | 0.4 | $1.8M | 243k | 7.36 | |
| Scynexis Com New (SCYX) | 0.2 | $829k | 1.2M | 0.67 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $580k | 135k | 4.31 | |
| Altimmune Com New (ALT) | 0.1 | $406k | 105k | 3.87 | |
| Enliven Therapeutics (ELVN) | 0.0 | $227k | 11k | 20.06 | |
| Reviva Pharmaceutcls Hldgs I (RVPH) | 0.0 | $53k | 138k | 0.38 |
